Phase IIIb Randomized Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer. A Joint Study of the EORTC ROG and GUCG
Latest Information Update: 16 Aug 2024
At a glance
- Drugs Degarelix (Primary) ; Bicalutamide; Flutamide; Goserelin; Leuprorelin; Triptorelin
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms PEGASUS
- 28 Jun 2024 This trial has been completed in Denmark, according to European Clinical Trials Database record.
- 24 Jun 2024 This trial has been completed in France, according to European Clinical Trials Database record.
- 02 Apr 2024 Planned End Date changed from 1 Jun 2024 to 1 Jun 2026.